The gain of function of the p53 mutant Asp281Gly is dependent on its ability to form tetramers

被引:11
作者
Atema, A
Chène, P
机构
[1] Novartis, Oncol Dept, CH-4002 Basel, Switzerland
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
p53; gain of function; tetramerisation; chemoresistance; chemosensitivity;
D O I
10.1016/S0304-3835(02)00318-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The influence of tetramerisation on the properties of the p53 mutants is poorly understood. We describe here the influence of tetramerisation on the properties of the oncogenic mutant Asp281Gly. We show that despite being both nuclear the tetrameric Asp281Gly and the monomeric Asp281GlyLeu344Pro proteins have different properties: only Asp281 Gly stimulates the transcription of the multidrug resistance-1 gene promoter and induces cisplatin resistance in Saos-2 cells. Moreover, we identify a 130-kDa protein that specifically interacts with Asp281Gly but not with Asp281GlyLeu344Pro. This suggests that tetramerisation is important for the properties of the p53 mutants and that these properties might be mediated via protein-protein interactions. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 25 条
[1]  
Atz J, 2000, J CELL BIOCHEM, V76, P572, DOI 10.1002/(SICI)1097-4644(20000315)76:4<572::AID-JCB6>3.0.CO
[2]  
2-6
[3]   4 P53 DNA-BINDING DOMAIN PEPTIDES BIND NATURAL P53-RESPONSE ELEMENTS AND BEND THE DNA [J].
BALAGURUMOORTHY, P ;
SAKAMOTO, H ;
LEWIS, MS ;
ZAMBRANO, N ;
CLORE, GM ;
GRONENBORN, AM ;
APPELLA, E ;
HARRINGTON, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) :8591-8595
[4]   Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy [J].
Blandino, G ;
Levine, AJ ;
Oren, M .
ONCOGENE, 1999, 18 (02) :477-485
[5]   Cellular characterisation of p53 mutants with a single missense mutation in the β-strand 326-333 and correlation of their cellular activities with in vitro properties [J].
Chène, P ;
Bechter, E .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 288 (05) :891-897
[6]   In vitro analysis of the dominant negative effect of p53 mutants [J].
Chène, P .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 281 (02) :205-209
[7]   p53 mutants without a functional tetramerisation domain are not oncogenic [J].
Chène, P ;
Bechter, E .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 286 (05) :1269-1274
[8]   In vitro structure-function analysis of the beta-strand 326-333 of human p53 [J].
Chene, P ;
Mittl, P ;
Grutter, M .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 273 (04) :873-881
[9]   Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome [J].
Davison, TS ;
Yin, P ;
Nie, E ;
Kay, C ;
Arrowsmith, CH .
ONCOGENE, 1998, 17 (05) :651-656
[10]   GAIN OF FUNCTION MUTATIONS IN P53 [J].
DITTMER, D ;
PATI, S ;
ZAMBETTI, G ;
CHU, S ;
TERESKY, AK ;
MOORE, M ;
FINLAY, C ;
LEVINE, AJ .
NATURE GENETICS, 1993, 4 (01) :42-46